What is happening?
Our latest services and competencies
Recent investments, latest news and other events!
Press releases
Join Adragos Pharma at CPHI Barcelona 2023 – October 24-26
Dear Valued Partners and Industry Enthusiasts, We are thrilled to announce that the Adragos Pharma team will be participating in one of the pharmaceutical industry’s
Adragos Pharma Announces Divestiture of Toride Pharma K.K. and Toride Asset Trading Co. Ltd.
Munich, Germany / Tokyo, Japan, June 15, 2023 — Adragos Pharma GmbH, a global leader in pharmaceutical manufacturing, announced today that it has completed the
Successful transaction: Adragos Pharma has officially taken over Clinigen’s development unit, Lamda Laboratories near Athens, Greece
Adragos on a growth path: Three locations in Europe and five globally Acquisition strengthens Adragos’ end-to-end integrated pharmaceutical product development service offering Agreement on further
Adragos Pharma acquires Clinigen’s development unit, Lamda Laboratories in Greece, Athens
Adragos Pharma acquires Clinigen’s development unit, Lamda Laboratories Acquisition strengthens Adragos end-to-end integrated service offering within the pharmaceutical product development segment Agreement includes further product
Successful transaction: Adragos Pharma has officially taken over the Sanofi production site in Kawagoe, Japan
Successful transaction: Adragos Pharma has officially taken over the Sanofi production site in Kawagoe, Japan Munich / Paris / Tokyo, March 02, 2023 – Munich-based
Adragos Pharma to acquire Sanofi’s manufacturing site in Kawagoe, Japan
Adragos Pharma to acquire Sanofi’s manufacturing site in Kawagoe, Japan Munich / Paris / Tokyo, October 13, 2022 – Adragos Pharma, a rapidly growing pharmaceutical
